In vivo molecular imaging using Thy1-scFv (single-chain variable fragment) conjugated to an ultrasound contrast agent (MBThy1-scFv) demonstrated signal enhancement on a transgenic pancreatic ductal adenocarcinoma (PDAC) mouse model, suggesting potential for the early diagnosis of PDAC [29]. Here, THY1 is linked to pancreatic ductal adenocarcinoma.